References
Vorobioff J, Bredfeldt JE, Groszmann RJ: Increased blood flow through the portal system in cirrhotic rats. Gastroenterology 1984;87:1120
Rikkers LF: New concepts of pathophysiology and treatment of portal hypertension. Surgery 1990;107:481
Benoit JN, Barrowman JA, Harper SL, et al: Role of glucagon in splanchnic hyperemia of chronic portal hypertension. Am J Physiol 1986;251:G674
Sherwin R, Joshi P, Hendler, R et al: Hyperglucagonemia in Laennec’s cirrhosis-the role of portal-systemic shunting. N Engl J Med 1974;290:239
Kiel JW, Pitts V, Benoit JN, et al: Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats. Am J Physiol 1985;248:G192
Sitzmann JV, Li SS, Pin PW: Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension. J Surg Res 1989;47:208
Lebrec D: Current status and future goals of the pharmacologic reduction of portal hypertension. Am J Surg 1990;160:19
Burroughs AK, Jenkins WJ, Sherlock S, et al: Controlled trial of propranolol for prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med 1983;309:1539
Villeneuve JP, Pomier-Layragues G, Infant-Rivard C, et al: Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial. Hcpatology 1986:6:1239
Pascal JP, Cales P: Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. A Multicenter Study Group. N Engl J Med 1987:317:856
Moreau R, Lee SS, Hadenguc A, et al: Hemodynamic effects of a clonidine-induced decrease in sympathetic tone in patients with cirrhosis. Hepatology 1987;7:149
Cummings SA, Groszmann RJ, Kaumann AJ: Hypersensitivity of mesenteric veins to 5-hydroxytryptamine and kantserin-induced reduction of portal hypertension in portal hypertensive rats. Br J Pharmacol 1986;89:501
Vorobioff J, Garcia-Tsao G, Groszmann R, et al: Long-term hemodynamic effects of kantserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients. Hepatology 1989;9:88
Hadengue A, Moreau R, Cerini R, et al: Combination of kantserin and verapamil or propranolol in patients with alcoholic cirrhosis. Hepatology 1989:9:183
Resnick RH, Iber FL, Ishihara AM, et al: A controlled trial of the therapeutic portacaval shunt (Boston InterHospital Liver Group). Gastroenterology 1974:67:843
Reynolds TB, Donovan AJ, Mikkelsen WP, et al: Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices. Gastroenterology 1981;80:1005
Warren WD, Zeppa R, Fomon JJ: Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967;166:437
Rikkers LF: Is the distal splenorenal shunt better? Hepatology 1988;8:1705
Warren WD, Millikan WJ, Henderson JM, et al: Splenopancreatic disconnection: Improved selectivity of the distal splenorenal shunt. Ann Surg 1986;204:346
Henderson JM, Warren WD, Millikan WJ, et al: Distal splenorenal shunt with splenopancreatic disconnection: a four-year assesment. Ann Surg 1989:210:332
Johansen K: Partial portal decompression for variceal hemorrhage. Am J Surg 1989;157:479
Sarfeh IJ, Rypins EB, Conroy RM, et al: Portacaval H-Graft: Relationships of shunt diameter, portal flow patterns and encephalopathy. Ann Surg 1983;197:442
Johnson A, Rogers H: A review of 15-tears’s experience in the use of sclerotherapy in the control of acute hemorrhage from esophageal varices. Br J Surg 1973;60:797
Clark A, Mithchell K: Prospective, controlled, clinical trial of injection sclerotherapy in cirrhotic patients with recent variceal hemorrhage. Lancet 1980:2:252
McDougall BRD, Westaby D: Increased long-term survival in variceal hemorrhage using injection sclerotherapy. Lancet 1981:1:124
Teres J, Baroni R, Bordas JM, et al: Randomized trial of portacaval shunt, stapling transection and endoscopie sclerotherapy in uncontrolled variceal bleeding. J Hepatol 1987;4:159
Warren WD, Henderson JM, Millikan WJ, et al: Distal splenorenal shunt versus endoscopic sclertotherapy for long-term management of variceal bleeding; preliminary report of a prospective, randomized trial. Ann Surg 1986;203:545
Rikkers LF, Burnett DF, Volentine DG, et al: Shunt surgery vs endoscopie sclerotherapy for long-term treatment of variceal bleeding. Ann Surg 1987;206:261
Cello JP, Grendell JH, Crass RA, et al: Endoscopie sclerotherapy vs portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage: long-term follow-up. N Engl J Mcd 1987;316-11
Bismuth H, Adam R, Surendra M, et al: Options for elective treatment of portal hypertension in cirrhotic patients in the transplantation era. Am J Surg 1990:160:105
Iwatsuki S, Starzl TE, Todo S, et al: Liver transplantation in the treatment of bleeding esophagcal varices. Surgery 1988:104: 697
Millikan WJ, Henderson JM, Stewart MT, et al: Change in hepatic function, hemodynamics and morphology after liver trans plantation. Ann Surg 1989;209:513
Mazzaferro V, Todo S, Tzakis AG, et al: Liver transplantaion in patients with previous portasystemic shunt. Am J Surg 1990:160; 111
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eckhauser, F.E., Raper, S.E., Mulholland, M.W. et al. Current concepts in the pathophysiology and treatment of portal hypertension and variceal hemorrhage. Gastroenterol Jpn 26 (Suppl 3), 1–8 (1991). https://doi.org/10.1007/BF02779252
Issue Date:
DOI: https://doi.org/10.1007/BF02779252